Abstract:Background Chronic knee pain due to osteoarthritis (OA) is expected to become more prevalent. Although conventional therapies may provide relief they are not long-lasting. Persistent pain may lead to total knee replacement, which is not free of adverse outcomes. Monopolar and cooled radiofrequency ablation (RFA) of genicular nerves is an effective option. However, either method may provide distinctive results depending on expected lesion size, a key aspect considering the anatomical variability of knee innervations. This prospective, double-blind, randomized controlled trial evaluated the efficacy and durability of knee RFA using a cooled probe or a monopolar probe of comparable diameter. Methods This investigator-initiated, post-market, double-blinded, prospective, randomized controlled trial was approved by the Western IRB. 79 subjects with chronic knee pain due to knee OA were enrolled in multiple locations of a single center. 75 subjects were randomized (1:1) into RFA treatment with either a 4 mm/17G cooled active tip (CRFA) or a 10 mm/16G monopolar active tip (MRFA) using conventional procedures. Primary endpoint was change in knee pain level (100 mm VAS score) from baseline at 24-week post-treatment. Other endpoints include change in functionality, global perceived effect, and frequency of adverse events. Evaluation spanned to 52-week post-treatment. Significance of results (p < 0.05) was calculated using standard statistical analyses. Results Both CRFA and MRFA provided significant reduction (41 mm and 39 mm, respectively) of chronic knee pain at 24-week. At the 52-week visit, reduction in pain level was sustained for CRFA (42 mm) but seems to decrease for MRFA (31 mm). Improvements in functionality were also significant and sustained with both treatments, although tend to decrease with MRFA at 52-week. Most patients also perceived a very good/good effect of treatments along the duration of the study. Conclusion RFA of knee genicular nerves for the treatment of OA chronic pain is effective for 52 weeks post-ablation when using a CRFA (4 mm/17G active tip) or MRFA (10 mm/16G active tip). The benefits of CRFA seems to be better sustained beyond 24 weeks than the ones of MRFA, although no significant differences were observed at 52 weeks.

Types of Radiofrequency Ablation-Cooled Radiofrequency Ablation

Research progress and clinical application of cooled radiofrequency ablation

Basic Aspects of Radiofrequency Catheter Ablation

Types of Radiofrequency Ablation-Pulsed Radiofrequency Ablation

[Technical principles of ablation therapy]

History, Principles, and Techniques of Radiofrequency Ablation

Radiofrequency Ablation for Thoracic and Abdominal Chronic Pain Syndromes

Mechanism of Action of Radiofrequency Ablation

A review of the general aspects of radiofrequency ablation

Mitigating Factors in L4 and L5 Medial Branch Motor Stimulation During Radiofrequency Ablation

A randomized controlled study of the long-term efficacy of cooled and monopolar radiofrequency ablation for the treatment of chronic pain related to knee osteoarthritis

Radiofrequency ablation: technique and clinical applications

Radiofrequency ablation: mechanisms and clinical applications

Radiofrequency Ablation for Craniofacial Pain Syndromes

The Role of Radiofrequency Ablation in Benign and Malignant Thyroid Nodules

Cooling or Warming the Esophagus to Reduce Esophageal Injury During Left Atrial Ablation in the Treatment of Atrial Fibrillation

Cryoballoon Ablation, A Novel Technology for Atrial Fibrillation Treatment

Advances in radiofrequency ablation for thoracic spine pain

Review of Radiofrequency Ablation for Peripheral Nerves

Upper limb and lower limb radiofrequency treatments in orthopaedics

Novel Ablation Catheters for Atrial Fibrillation